C OSBORNE's research topics

C OSBORNE

Concepts (725)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Breast Neoplasms	249	2015	2582	8.210	Why?
Receptors, Estrogen	114	2015	714	5.270	Why?
Tamoxifen	74	2011	344	4.800	Why?
Antineoplastic Agents, Hormonal	48	2011	253	4.310	Why?
Poaceae	9	2025	15	2.030	Why?
Antineoplastic Combined Chemotherapy Protocols	48	2015	1301	2.010	Why?
Receptors, Progesterone	46	2012	663	1.900	Why?
Estrogen Antagonists	23	2011	94	1.650	Why?
Drug Resistance, Neoplasm	24	2011	772	1.490	Why?
Neoplasms, Hormone-Dependent	19	2011	92	1.410	Why?
Biomarkers, Tumor	30	2013	1559	1.360	Why?
Photosynthesis	5	2025	12	1.300	Why?
Estradiol	22	2010	476	1.230	Why?
Antineoplastic Agents	25	2015	1757	1.060	Why?
Quinazolines	7	2015	179	0.970	Why?
Estrogen Receptor Modulators	10	2005	39	0.850	Why?
Plant Leaves	5	2025	54	0.790	Why?
DNA, Neoplasm	18	2013	284	0.790	Why?
Aromatase Inhibitors	10	2015	78	0.770	Why?
Selective Estrogen Receptor Modulators	7	2010	52	0.760	Why?
Water	3	2025	186	0.760	Why?
Antibodies, Monoclonal, Humanized	5	2015	540	0.740	Why?
Growth Substances	9	2004	106	0.740	Why?
Female	215	2015	67915	0.700	Why?
Cyclophosphamide	34	2011	420	0.700	Why?
ErbB Receptors	16	2011	285	0.660	Why?
Chemotherapy, Adjuvant	25	2010	377	0.640	Why?
Estrogens	19	2006	424	0.630	Why?
Gene Expression Regulation, Neoplastic	22	2009	1936	0.630	Why?
Neoplasm Metastasis	22	2015	686	0.620	Why?
Nitriles	8	2015	149	0.590	Why?
Lymphatic Metastasis	34	2009	424	0.580	Why?
Humans	265	2015	126089	0.580	Why?
Doxorubicin	22	2011	286	0.570	Why?
Cell Division	35	2003	719	0.570	Why?
Tumor Cells, Cultured	28	2003	985	0.560	Why?
Fluorouracil	29	2010	133	0.530	Why?
Receptor Cross-Talk	5	2011	36	0.520	Why?
Disease-Free Survival	30	2010	898	0.520	Why?
Carcinoma	4	2015	279	0.520	Why?
Gene Transfer, Horizontal	2	2019	51	0.520	Why?
Triazoles	8	2015	129	0.500	Why?
Receptors, Growth Factor	3	2005	35	0.500	Why?
Prognosis	59	2015	4709	0.480	Why?
Carbon Dioxide	2	2014	271	0.480	Why?
Droughts	2	2021	12	0.470	Why?
Plant Proteins	2	2013	83	0.470	Why?
Genes, Plant	2	2019	38	0.430	Why?
Mice, Nude	24	2008	708	0.410	Why?
Evolution, Molecular	3	2019	683	0.410	Why?
Signal Transduction	21	2011	4468	0.400	Why?
Mucin-1	1	2013	34	0.400	Why?
Insulin-Like Growth Factor I	10	2006	314	0.400	Why?
Estrogen Receptor alpha	6	2008	419	0.380	Why?
Clinical Trials as Topic	16	2011	1096	0.370	Why?
Drug Resistance	14	2005	246	0.360	Why?
Immunohistochemistry	16	2010	1596	0.360	Why?
Middle Aged	85	2011	27331	0.360	Why?
Aged	67	2011	20005	0.360	Why?
Pregnancy Complications, Neoplastic	1	2011	63	0.350	Why?
Plants	2	2021	43	0.340	Why?
Survival Analysis	23	2007	1476	0.330	Why?
Lymph Nodes	15	2009	373	0.330	Why?
Methotrexate	23	2010	313	0.330	Why?
Receptors, Cell Surface	11	1995	423	0.330	Why?
Adenocarcinoma	9	2009	976	0.330	Why?
Gene Expression Profiling	8	2015	1763	0.330	Why?
Sirolimus	1	2012	223	0.320	Why?
Prednisone	17	2011	239	0.320	Why?
Repressor Proteins	6	2005	762	0.320	Why?
Lymphoma	4	2011	319	0.320	Why?
Heat-Shock Proteins	5	2011	176	0.300	Why?
Climate Change	3	2021	62	0.300	Why?
Biological Evolution	4	2023	233	0.300	Why?
Adult	71	2011	30254	0.300	Why?
Trees	2	2019	22	0.300	Why?
Ovariectomy	5	1998	166	0.290	Why?
Proportional Hazards Models	13	2009	1350	0.290	Why?
Vincristine	12	2011	190	0.280	Why?
Transcription Factors	6	2003	2341	0.270	Why?
Nuclear Proteins	7	2005	1205	0.270	Why?
Immunosuppressive Agents	1	2012	650	0.270	Why?
Aged, 80 and over	24	2011	6552	0.270	Why?
Somatomedins	4	1999	33	0.270	Why?
Postmenopause	11	2009	140	0.260	Why?
Antibiotics, Antineoplastic	5	2009	123	0.240	Why?
Ploidies	10	2000	33	0.240	Why?
Genes, erbB-1	1	2005	9	0.230	Why?
Trastuzumab	4	2015	145	0.230	Why?
Animals	55	2018	33120	0.230	Why?
Enzyme Inhibitors	5	2004	565	0.220	Why?
Epidermal Growth Factor	6	2004	111	0.220	Why?
Mitogen-Activated Protein Kinases	3	2003	186	0.220	Why?
Transcription Factor AP-1	2	2002	108	0.210	Why?
Antibodies, Monoclonal	10	2011	987	0.210	Why?
Receptors, Retinoic Acid	2	2003	75	0.210	Why?
Mammary Neoplasms, Experimental	5	1999	236	0.210	Why?
Cell Line	22	2003	2565	0.210	Why?
Goserelin	3	2005	4	0.210	Why?
Combined Modality Therapy	17	2005	1216	0.210	Why?
Neoplasms, Second Primary	1	2005	138	0.200	Why?
Neoplasm Proteins	8	2000	653	0.200	Why?
Adaptation, Physiological	1	2025	259	0.200	Why?
Proto-Oncogene Proteins c-bcl-2	4	1998	169	0.200	Why?
Antineoplastic Agents, Phytogenic	4	2005	101	0.200	Why?
Treatment Outcome	28	2011	12328	0.200	Why?
Prostatic Neoplasms	5	1992	1398	0.200	Why?
Computer Simulation	1	2006	664	0.190	Why?
Ecosystem	2	2020	108	0.190	Why?
Mice	36	2015	17585	0.190	Why?
Drug Administration Schedule	12	2007	727	0.190	Why?
Tumor Suppressor Protein p53	6	1998	726	0.190	Why?
Insulin-Like Growth Factor II	3	1992	38	0.190	Why?
Carcinoma, Ductal, Breast	4	2010	84	0.190	Why?
Genetic Markers	1	2003	599	0.180	Why?
Transforming Growth Factor alpha	4	1994	26	0.180	Why?
Survival Rate	15	2005	2060	0.180	Why?
Phylogeny	4	2020	719	0.180	Why?
Xylem	1	2021	3	0.180	Why?
Acclimatization	1	2021	21	0.170	Why?
Trans-Activators	3	2005	674	0.170	Why?
Transforming Growth Factors	5	1988	19	0.170	Why?
Phenotype	7	2021	4304	0.170	Why?
Predictive Value of Tests	14	2010	2190	0.170	Why?
Transfection	9	2002	947	0.170	Why?
HSP70 Heat-Shock Proteins	2	1998	69	0.170	Why?
Taxoids	3	2005	70	0.170	Why?
Plant Stomata	2	2025	7	0.170	Why?
Neoplasms, Experimental	6	1989	203	0.170	Why?
Genes, erbB-2	3	2011	32	0.160	Why?
Cell Proliferation	6	2011	2389	0.160	Why?
Polymorphism, Genetic	4	2010	788	0.160	Why?
Melphalan	4	2003	43	0.160	Why?
Mitoxantrone	7	1999	27	0.150	Why?
Databases, Factual	2	2021	1176	0.150	Why?
Neoplasm Transplantation	9	2006	361	0.150	Why?
Mesoderm	1	2009	104	0.150	Why?
Domestication	1	2018	3	0.150	Why?
Soil	1	2019	73	0.150	Why?
Molecular Targeted Therapy	2	2011	380	0.150	Why?
Crops, Agricultural	1	2018	16	0.150	Why?
Animals, Domestic	1	2018	33	0.150	Why?
Neoplasm, Residual	1	2009	131	0.150	Why?
Peptides	5	1988	828	0.140	Why?
Recombinant Fusion Proteins	4	2000	678	0.140	Why?
Nuclear Matrix-Associated Proteins	3	2005	19	0.140	Why?
Matrix Attachment Region Binding Proteins	3	2005	19	0.140	Why?
Carbon	2	2019	88	0.140	Why?
S Phase	8	2000	71	0.140	Why?
Disease Progression	11	2011	2099	0.140	Why?
Forests	1	2017	15	0.140	Why?
Menopause	10	2003	83	0.140	Why?
Multivariate Analysis	7	2004	1350	0.140	Why?
Time Factors	18	2010	6016	0.140	Why?
Dose-Response Relationship, Drug	8	2007	1593	0.140	Why?
Transcriptome	3	2015	1061	0.140	Why?
Anticarcinogenic Agents	2	2010	46	0.130	Why?
Tetrahydronaphthalenes	2	2010	30	0.130	Why?
Double-Blind Method	7	2010	1574	0.130	Why?
Transplantation, Heterologous	8	2006	251	0.130	Why?
Cathepsin D	2	1994	16	0.130	Why?
Neoplasm Invasiveness	6	2010	632	0.130	Why?
Drug Evaluation	8	1992	100	0.130	Why?
Flow Cytometry	9	1999	758	0.130	Why?
Receptors, Steroid	4	1992	162	0.130	Why?
Proto-Oncogene Proteins	4	1994	588	0.120	Why?
Loss of Heterozygosity	3	2001	122	0.120	Why?
Axilla	10	2005	39	0.120	Why?
Oxidative Stress	1	2000	754	0.120	Why?
Blotting, Western	5	2003	1014	0.120	Why?
Protein-Tyrosine Kinases	3	2011	220	0.120	Why?
Neoplasm Recurrence, Local	10	2010	1231	0.120	Why?
Phosphorylation	9	2008	1538	0.120	Why?
Hormones	5	1989	167	0.120	Why?
Superoxide Dismutase	2	2010	170	0.120	Why?
Hematopoietic Cell Growth Factors	2	1991	9	0.110	Why?
Receptors, Somatomedin	6	1999	21	0.110	Why?
Megestrol	2	1997	2	0.110	Why?
Models, Biological	5	2025	1370	0.110	Why?
Neutropenia	2	2010	198	0.110	Why?
Polymerase Chain Reaction	4	2009	1486	0.110	Why?
Insulin	7	1984	1131	0.110	Why?
Kinetics	10	1990	1090	0.110	Why?
Neoplastic Cells, Circulating	1	2015	76	0.110	Why?
Immunotoxins	1	1994	21	0.110	Why?
South Africa	1	2014	99	0.110	Why?
Nursing Assessment	1	1993	25	0.100	Why?
Granulocyte-Macrophage Colony-Stimulating Factor	1	1994	69	0.100	Why?
Gene Expression	5	2002	1485	0.100	Why?
Premenopause	5	2005	35	0.100	Why?
Orientation	1	1993	39	0.100	Why?
Mastectomy	7	2005	74	0.100	Why?
Phosphoproteins	3	2001	420	0.100	Why?
Logistic Models	5	2010	1745	0.100	Why?
Gene Amplification	3	2011	227	0.100	Why?
Analysis of Variance	6	1997	947	0.100	Why?
Histone Deacetylases	2	2005	113	0.100	Why?
Air	1	2013	21	0.100	Why?
Pyrrolidines	2	2010	45	0.100	Why?
Receptor, IGF Type 1	4	2011	92	0.100	Why?
Vinblastine	2	2011	55	0.100	Why?
Tyrphostins	1	1992	13	0.100	Why?
Histone Acetyltransferases	2	2003	224	0.100	Why?
Cell Line, Tumor	9	2015	3483	0.090	Why?
Data Collection	2	1993	367	0.090	Why?
Nurses	1	1993	77	0.090	Why?
Research Personnel	1	1993	124	0.090	Why?
Mice, Inbred BALB C	7	2004	987	0.090	Why?
Phosphotransferases	1	1992	33	0.090	Why?
Sequence Analysis, Protein	1	2012	47	0.090	Why?
Promoter Regions, Genetic	5	2006	1207	0.090	Why?
Plasmids	2	2002	445	0.090	Why?
Everolimus	1	2012	48	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2011	59	0.090	Why?
Genes, Tumor Suppressor	3	2001	198	0.090	Why?
Phosphotransferases (Alcohol Group Acceptor)	1	1992	77	0.090	Why?
Bleomycin	1	2011	110	0.090	Why?
Dacarbazine	1	2011	91	0.090	Why?
Nuclear Receptor Coactivator 3	2	2003	253	0.090	Why?
Genetic Vectors	2	1994	889	0.090	Why?
Forecasting	3	2005	350	0.090	Why?
Molecular Sequence Data	5	2012	3599	0.090	Why?
Antineoplastic Agents, Alkylating	3	2010	95	0.090	Why?
Activities of Daily Living	1	1993	403	0.090	Why?
Motivation	1	1993	322	0.090	Why?
Follow-Up Studies	10	2007	5050	0.080	Why?
Fertility Preservation	1	2011	61	0.080	Why?
Pyridines	1	1992	248	0.080	Why?
Women's Health	1	2012	135	0.080	Why?
Osteoporosis, Postmenopausal	1	2010	31	0.080	Why?
Cell Cycle	7	2006	585	0.080	Why?
Paclitaxel	2	2003	128	0.080	Why?
Quality of Life	4	2002	2023	0.080	Why?
Sequence Alignment	1	2012	587	0.080	Why?
Rituximab	1	2011	165	0.080	Why?
Placebos	1	2011	224	0.080	Why?
Health Planning Guidelines	1	2010	33	0.080	Why?
Southwestern United States	3	2010	44	0.080	Why?
Amino Acid Sequence	3	2012	2544	0.080	Why?
Metabolic Networks and Pathways	1	2010	192	0.080	Why?
Transcription, Genetic	3	2008	1378	0.080	Why?
Peroxidase	1	2009	60	0.080	Why?
Acronine	1	1989	1	0.080	Why?
Biopsy, Needle	5	2005	214	0.080	Why?
Treatment Failure	4	2010	331	0.080	Why?
Tumor Necrosis Factor-alpha	1	1991	638	0.070	Why?
Guidelines as Topic	1	2010	192	0.070	Why?
Apoptosis	4	2005	1805	0.070	Why?
Alkaloids	1	1989	36	0.070	Why?
Ki-67 Antigen	3	2000	100	0.070	Why?
Disease Models, Animal	6	2015	4409	0.070	Why?
DNA	4	2006	1422	0.070	Why?
Nitric Oxide Synthase Type III	1	2009	189	0.070	Why?
Nuclear Receptor Co-Repressor 1	3	2005	50	0.070	Why?
Fractures, Bone	1	2010	187	0.070	Why?
DNA-Binding Proteins	4	2000	1886	0.070	Why?
Pregnancy Outcome	1	2011	625	0.070	Why?
Drug Screening Assays, Antitumor	3	1994	105	0.070	Why?
Drug-Related Side Effects and Adverse Reactions	1	2011	259	0.070	Why?
Biopsy	7	2009	1234	0.070	Why?
Cell Nucleus	5	2000	554	0.070	Why?
Transcriptional Activation	2	2000	413	0.070	Why?
Immunologic Factors	1	1989	182	0.070	Why?
Attitude of Health Personnel	1	1993	693	0.070	Why?
Neoadjuvant Therapy	6	2006	378	0.070	Why?
Chromatography, High Pressure Liquid	4	1994	334	0.070	Why?
Binding, Competitive	3	2000	153	0.070	Why?
United States	12	2010	11204	0.070	Why?
Anthraquinones	2	1985	9	0.070	Why?
Estrogen Receptor beta	2	2004	81	0.070	Why?
North America	2	2010	250	0.070	Why?
Protein Kinase Inhibitors	1	2011	576	0.070	Why?
Protein Binding	5	2004	1661	0.070	Why?
Receptors, Interleukin	1	2006	33	0.060	Why?
Pain Management	1	1989	195	0.060	Why?
Ligands	4	2004	477	0.060	Why?
Cytosol	3	1997	139	0.060	Why?
Receptors, Somatotropin	1	2006	9	0.060	Why?
Oligonucleotide Array Sequence Analysis	4	2008	1002	0.060	Why?
Benzamides	1	2006	120	0.060	Why?
Glutathione Transferase	2	2010	145	0.060	Why?
Neoplasms	6	2012	2848	0.060	Why?
Medroxyprogesterone	2	1985	8	0.060	Why?
Anthracenes	6	1991	8	0.060	Why?
Decision Making	2	2003	667	0.060	Why?
Human Growth Hormone	1	2006	76	0.060	Why?
MicroRNAs	1	2012	871	0.060	Why?
Carrier Proteins	1	1990	1011	0.060	Why?
Neoplasm Staging	6	2007	1281	0.060	Why?
Prospective Studies	5	2010	6093	0.060	Why?
Plant Transpiration	1	2025	3	0.060	Why?
Tumor Stem Cell Assay	1	1985	33	0.060	Why?
Colony-Forming Units Assay	1	1985	60	0.060	Why?
RNA, Messenger	5	2002	2547	0.060	Why?
Mastectomy, Radical	3	2003	9	0.060	Why?
Drug Approval	1	2005	41	0.060	Why?
p38 Mitogen-Activated Protein Kinases	1	2005	119	0.060	Why?
Insulin-Like Growth Factor Binding Proteins	2	1997	31	0.050	Why?
Proteinuria	1	2005	107	0.050	Why?
Dog Diseases	1	2005	58	0.050	Why?
JNK Mitogen-Activated Protein Kinases	2	2002	83	0.050	Why?
RNA, Neoplasm	4	1990	129	0.050	Why?
In Situ Hybridization	2	1995	450	0.050	Why?
Injections, Intramuscular	1	2004	182	0.050	Why?
Cell Size	1	2023	79	0.050	Why?
Androstenedione	1	2003	15	0.050	Why?
Homeodomain Proteins	1	2006	538	0.050	Why?
Algorithms	4	2010	1619	0.050	Why?
Metallothionein	2	1994	16	0.050	Why?
Nuclear Receptor Coactivator 1	1	2003	160	0.050	Why?
Oncogene Proteins, Viral	2	1994	60	0.050	Why?
Creatinine	1	2005	378	0.050	Why?
Acetyltransferases	1	2003	72	0.050	Why?
Genetic Testing	1	2009	1060	0.050	Why?
Clinical Trials, Phase III as Topic	3	2009	72	0.050	Why?
Bone Density	2	2010	351	0.050	Why?
Chromosomes, Human, Pair 14	2	2001	96	0.050	Why?
Infusions, Intravenous	3	2007	525	0.050	Why?
Breast	4	2003	208	0.050	Why?
Genes, Dominant	1	2003	241	0.050	Why?
Proteins	2	2001	1015	0.050	Why?
Lymphoma, Large B-Cell, Diffuse	4	1983	152	0.050	Why?
Cisplatin	4	2009	269	0.050	Why?
Oncogene Proteins	1	2003	133	0.050	Why?
Structure-Activity Relationship	2	2000	565	0.050	Why?
Retrospective Studies	10	2009	16770	0.050	Why?
Statistics as Topic	3	1999	238	0.050	Why?
Research	3	1995	253	0.050	Why?
Administration, Oral	1	2004	666	0.050	Why?
Immunoenzyme Techniques	2	2004	236	0.050	Why?
Mastectomy, Segmental	2	2004	39	0.050	Why?
Plant Physiological Phenomena	1	2021	8	0.050	Why?
Salvage Therapy	1	2003	171	0.040	Why?
Hyperbaric Oxygenation	2	1973	20	0.040	Why?
Randomized Controlled Trials as Topic	4	2009	1175	0.040	Why?
Stereoisomerism	2	1992	113	0.040	Why?
Odds Ratio	3	2010	1189	0.040	Why?
BRCA1 Protein	2	1999	77	0.040	Why?
Phorbols	1	1981	5	0.040	Why?
Radioimmunoassay	2	1991	98	0.040	Why?
Nucleoside-Diphosphate Kinase	1	2001	4	0.040	Why?
Climate	1	2021	23	0.040	Why?
Australia	1	2021	154	0.040	Why?
Biophysical Phenomena	1	2021	38	0.040	Why?
Phorbol Esters	1	1981	21	0.040	Why?
Monomeric GTP-Binding Proteins	1	2001	28	0.040	Why?
Chloramphenicol O-Acetyltransferase	1	2000	59	0.040	Why?
Chromosomes, Human, Pair 19	1	2001	59	0.040	Why?
Azacitidine	1	2001	51	0.040	Why?
Enhancer Elements, Genetic	1	2002	271	0.040	Why?
Cold Temperature	1	2021	81	0.040	Why?
Proto-Oncogene Proteins c-jun	1	2000	36	0.040	Why?
Pentose Phosphate Pathway	1	2000	43	0.040	Why?
Muscle Proteins	1	2003	397	0.040	Why?
Risk Factors	10	2010	10397	0.040	Why?
Proto-Oncogene Proteins c-akt	2	2008	477	0.040	Why?
Plant Dispersal	1	2020	1	0.040	Why?
Lipid Peroxidation	1	2000	90	0.040	Why?
Glucocorticoids	3	1979	339	0.040	Why?
Risk Assessment	4	2010	3461	0.040	Why?
Urokinase-Type Plasminogen Activator	2	1997	33	0.040	Why?
Carbon Sequestration	1	2019	6	0.040	Why?
Aneuploidy	1	2000	139	0.040	Why?
Reverse Transcriptase Polymerase Chain Reaction	3	2009	1225	0.040	Why?
Plasminogen Activator Inhibitor 1	2	1997	50	0.040	Why?
Claudin-1	1	2009	19	0.040	Why?
Insulin Antagonists	1	1979	4	0.040	Why?
Protein Kinases	2	2008	320	0.040	Why?
CD24 Antigen	1	2009	30	0.040	Why?
Gene Expression Regulation, Plant	1	2019	63	0.040	Why?
Molecular Weight	2	1990	298	0.040	Why?
Hyaluronan Receptors	1	2009	64	0.040	Why?
Leukocyte Count	2	2009	246	0.040	Why?
Genome	2	2019	483	0.040	Why?
Pregnancy	2	2011	7404	0.040	Why?
Gene Dosage	2	2008	440	0.040	Why?
Patient Selection	3	2009	702	0.040	Why?
Breast Neoplasms, Male	1	1998	17	0.040	Why?
Cyclins	1	1999	94	0.040	Why?
Depression, Chemical	2	2000	34	0.040	Why?
Epithelium	1	2009	335	0.040	Why?
Down-Regulation	3	2005	648	0.040	Why?
Antimetabolites, Antineoplastic	3	2009	170	0.040	Why?
Injections, Intraperitoneal	2	1989	66	0.030	Why?
Hormone Antagonists	1	1998	45	0.030	Why?
Medical Oncology	2	2010	229	0.030	Why?
DNA Replication	2	1989	342	0.030	Why?
Aminoglutethimide	1	1997	3	0.030	Why?
Immunoblotting	2	2004	292	0.030	Why?
Mammography	2	2010	129	0.030	Why?
Centrifugation	1	1997	23	0.030	Why?
Cell Survival	3	1989	841	0.030	Why?
Endometrial Neoplasms	1	1998	108	0.030	Why?
Cell Movement	1	2001	847	0.030	Why?
Cytodiagnosis	1	1997	18	0.030	Why?
Recombinant Proteins	2	1991	1293	0.030	Why?
Lung Neoplasms	4	2015	1494	0.030	Why?
Cell Membrane	1	2009	449	0.030	Why?
Drug Synergism	2	2008	231	0.030	Why?
Age Factors	3	2007	2772	0.030	Why?
Telomerase	1	1997	153	0.030	Why?
Nucleic Acids	2	2012	23	0.030	Why?
Kidney Failure, Chronic	1	2005	923	0.030	Why?
DNA Primers	4	1999	602	0.030	Why?
Receptor, Insulin	5	1999	58	0.030	Why?
Thymidine	3	1982	51	0.030	Why?
Hydrocortisone	1	1997	221	0.030	Why?
Phosphatidylinositol 3-Kinases	1	2008	330	0.030	Why?
Chromosomal Proteins, Non-Histone	1	1997	205	0.030	Why?
DNA Damage	1	1999	492	0.030	Why?
Testosterone	1	1982	600	0.030	Why?
Societies, Medical	2	2010	726	0.030	Why?
Cytoplasm	2	1995	250	0.030	Why?
Male	15	2005	62089	0.030	Why?
Polyethylene Glycols	1	1997	240	0.030	Why?
TOR Serine-Threonine Kinases	1	2008	415	0.030	Why?
Quality-Adjusted Life Years	1	1996	123	0.030	Why?
Leukopenia	3	1985	43	0.030	Why?
Interphase	2	1987	35	0.030	Why?
Mutation	4	2003	5926	0.030	Why?
Hyperplasia	3	2005	186	0.030	Why?
Chromosome Deletion	1	1998	642	0.030	Why?
Hematopoietic Stem Cell Transplantation	1	2003	1163	0.030	Why?
Remission Induction	2	1998	297	0.030	Why?
Culture Media, Conditioned	1	1994	82	0.030	Why?
Cell Transformation, Neoplastic	2	1998	606	0.030	Why?
Clone Cells	3	1985	164	0.030	Why?
Chi-Square Distribution	1	1996	542	0.030	Why?
Palliative Care	1	1998	438	0.030	Why?
DNA Methylation	1	2001	1036	0.030	Why?
Bone Neoplasms	3	2000	427	0.030	Why?
Heterografts	1	2015	189	0.030	Why?
Stimulation, Chemical	1	1994	42	0.030	Why?
Isomerism	1	1994	25	0.030	Why?
Follicle Stimulating Hormone	1	1994	184	0.030	Why?
Hematologic Tests	1	1994	36	0.030	Why?
Rats	6	2000	3387	0.030	Why?
Cloning, Molecular	2	1993	786	0.030	Why?
Castration	3	1985	31	0.030	Why?
Quality Control	1	1993	113	0.030	Why?
Protein Biosynthesis	1	1996	565	0.030	Why?
Vitamin E Deficiency	1	1973	2	0.020	Why?
Peroxides	1	1973	7	0.020	Why?
Dexamethasone	3	1980	261	0.020	Why?
Base Sequence	4	2000	2770	0.020	Why?
Methemoglobinemia	1	1973	9	0.020	Why?
Recurrence	3	2009	1400	0.020	Why?
Chromosome Aberrations	1	1995	570	0.020	Why?
Hemolysis	1	1973	102	0.020	Why?
Xenograft Model Antitumor Assays	2	2008	930	0.020	Why?
Up-Regulation	2	2005	826	0.020	Why?
Erythrocytes	1	1973	191	0.020	Why?
RNA Stability	1	2012	76	0.020	Why?
Carcinoma in Situ	1	1992	72	0.020	Why?
Carcinoma, Intraductal, Noninfiltrating	1	1992	67	0.020	Why?
Membrane Proteins	1	2009	1568	0.020	Why?
Gene Expression Regulation	3	1998	2313	0.020	Why?
Antisense Elements (Genetics)	1	1991	4	0.020	Why?
Electrophoresis, Agar Gel	1	1991	41	0.020	Why?
Templates, Genetic	1	1991	56	0.020	Why?
Burnout, Professional	1	1993	127	0.020	Why?
Oxidoreductases, N-Demethylating	1	2010	9	0.020	Why?
Cytochrome P-450 CYP2B6	1	2010	15	0.020	Why?
Inactivation, Metabolic	1	2010	28	0.020	Why?
Glutathione S-Transferase pi	1	2010	25	0.020	Why?
Angiogenesis Inhibitors	1	2011	106	0.020	Why?
Aryl Hydrocarbon Hydroxylases	1	2010	39	0.020	Why?
Diethylstilbestrol	1	1990	42	0.020	Why?
Sex Hormone-Binding Globulin	1	2010	49	0.020	Why?
Cytochrome P-450 CYP3A	1	2010	47	0.020	Why?
Orchiectomy	1	1990	53	0.020	Why?
False Negative Reactions	1	2010	86	0.020	Why?
Cohort Studies	3	2006	4920	0.020	Why?
Bone Density Conservation Agents	1	2010	57	0.020	Why?
Alanine	1	1991	162	0.020	Why?
Insulin Receptor Substrate Proteins	2	2001	74	0.020	Why?
False Positive Reactions	1	2010	133	0.020	Why?
Research Design	2	2005	687	0.020	Why?
Uridine	2	1980	31	0.020	Why?
Cancer Vaccines	1	2011	188	0.020	Why?
Lipid Metabolism	1	1973	353	0.020	Why?
Karyotyping	2	1987	313	0.020	Why?
Sensitivity and Specificity	2	2010	2029	0.020	Why?
Cells, Cultured	7	1987	2902	0.020	Why?
Patient Care Team	1	1993	548	0.020	Why?
Primary Prevention	1	2010	172	0.020	Why?
Microfilament Proteins	2	2003	264	0.020	Why?
Buserelin	1	1989	1	0.020	Why?
Transforming Growth Factor beta	1	1992	447	0.020	Why?
Pilot Projects	3	1999	1386	0.020	Why?
Oncogenes	1	1989	162	0.020	Why?
Cell Adhesion	1	1989	298	0.020	Why?
Bone Marrow Transplantation	1	1991	571	0.020	Why?
Solubility	1	1989	120	0.020	Why?
Adolescent	3	2005	19936	0.020	Why?
Affinity Labels	1	1988	10	0.020	Why?
Biological Availability	1	1989	135	0.020	Why?
Linear Models	1	1990	673	0.020	Why?
Gene Frequency	1	2010	738	0.020	Why?
CHO Cells	2	2000	148	0.020	Why?
3T3 Cells	2	2000	120	0.020	Why?
Cricetinae	2	2000	365	0.020	Why?
Culture Techniques	2	1978	74	0.020	Why?
Fatty Acids	3	1983	351	0.020	Why?
Nausea	2	1985	78	0.020	Why?
Biological Products	1	1989	136	0.020	Why?
Agar	1	1987	17	0.020	Why?
Kaplan-Meier Estimate	1	2009	1025	0.020	Why?
Microscopy, Electron	1	1987	307	0.020	Why?
Choline Dehydrogenase	1	2006	2	0.020	Why?
Tissue Distribution	2	1997	362	0.020	Why?
Receptors, Interleukin-17	1	2006	7	0.020	Why?
Adrenalectomy	3	1978	40	0.020	Why?
Injections, Subcutaneous	1	1987	129	0.020	Why?
Culture Media	2	1984	170	0.020	Why?
Delayed-Action Preparations	1	1987	115	0.020	Why?
Mitosis	1	1987	190	0.020	Why?
Probability	1	2007	297	0.020	Why?
Response Elements	1	2006	99	0.020	Why?
Evidence-Based Medicine	1	2010	606	0.020	Why?
Statistics, Nonparametric	1	2007	418	0.020	Why?
Ethics, Medical	1	1989	399	0.020	Why?
Liver Neoplasms	3	2003	1350	0.020	Why?
Immunologic Techniques	1	1985	8	0.010	Why?
Health Status Disparities	1	2009	257	0.010	Why?
Endpoint Determination	1	2005	51	0.010	Why?
Phenylalanine	1	1986	120	0.010	Why?
Chemoprevention	1	2005	51	0.010	Why?
Random Allocation	4	1989	414	0.010	Why?
Mammary Glands, Human	1	2006	80	0.010	Why?
Chromatin Immunoprecipitation	1	2005	229	0.010	Why?
Risk	2	1998	726	0.010	Why?
Raloxifene Hydrochloride	1	1985	16	0.010	Why?
Confidence Intervals	1	2005	255	0.010	Why?
Medroxyprogesterone Acetate	1	1985	21	0.010	Why?
Research Support as Topic	1	2005	59	0.010	Why?
Drug Evaluation, Preclinical	1	1984	147	0.010	Why?
Nafoxidine	1	1984	4	0.010	Why?
Guinea Pigs	1	1984	157	0.010	Why?
Phlebitis	1	1984	1	0.010	Why?
Chickens	1	1984	284	0.010	Why?
Growth Hormone	1	1984	125	0.010	Why?
Analgesics, Opioid	1	1989	451	0.010	Why?
Radiotherapy	1	2004	120	0.010	Why?
Binding Sites	1	2006	1187	0.010	Why?
Dogs	1	2005	603	0.010	Why?
Patient Care Planning	1	2005	122	0.010	Why?
Rabbits	1	1984	612	0.010	Why?
Leydig Cell Tumor	1	1983	7	0.010	Why?
Protein Isoforms	1	2004	402	0.010	Why?
Hypercalcemia	1	1983	42	0.010	Why?
Species Specificity	1	1984	519	0.010	Why?
Megestrol Acetate	1	2003	2	0.010	Why?
Thiotepa	1	2003	17	0.010	Why?
Editorial Policies	1	2004	48	0.010	Why?
Reproducibility of Results	1	2010	2875	0.010	Why?
Case-Control Studies	1	2010	3303	0.010	Why?
Genotype	1	2009	2600	0.010	Why?
Bone Resorption	1	1983	50	0.010	Why?
RNA, Small Interfering	1	2005	658	0.010	Why?
Toremifene	1	2003	1	0.010	Why?
Mastectomy, Modified Radical	1	2003	7	0.010	Why?
Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)	1	2002	1	0.010	Why?
Piperidines	1	1985	224	0.010	Why?
Culture Media, Serum-Free	1	2002	23	0.010	Why?
Genes, Neoplasm	1	2003	81	0.010	Why?
Incidence	1	2010	3213	0.010	Why?
Antibody Specificity	1	2003	196	0.010	Why?
Transplantation, Autologous	1	2003	264	0.010	Why?
In Situ Hybridization, Fluorescence	1	2004	749	0.010	Why?
Progesterone	1	1985	430	0.010	Why?
Thyroid Hormones	1	2003	56	0.010	Why?
Cause of Death	1	2005	473	0.010	Why?
Cell Differentiation	1	1989	1849	0.010	Why?
Neoplastic Stem Cells	1	1985	331	0.010	Why?
Antigens, Neoplasm	1	2005	400	0.010	Why?
Acetates	2	1979	80	0.010	Why?
Thrombocytopenia	1	1983	222	0.010	Why?
Severity of Illness Index	1	2010	2936	0.010	Why?
Spinal Cord Compression	1	1982	26	0.010	Why?
Hemagglutinins	1	2001	25	0.010	Why?
Anaphylaxis	1	1983	86	0.010	Why?
Chromosomes, Artificial, Yeast	1	2001	42	0.010	Why?
Physical Chromosome Mapping	1	2001	54	0.010	Why?
NM23 Nucleoside Diphosphate Kinases	1	2001	4	0.010	Why?
Expressed Sequence Tags	1	2001	79	0.010	Why?
Cyclin D1	1	2001	108	0.010	Why?
Regression Analysis	2	1998	757	0.010	Why?
Chromosomes, Artificial, Bacterial	1	2001	92	0.010	Why?
Receptors, Glucocorticoid	2	1979	105	0.010	Why?
Swine	1	1984	1164	0.010	Why?
Precancerous Conditions	1	2003	277	0.010	Why?
Antigens, Nuclear	1	2001	53	0.010	Why?
Menstruation	1	1980	26	0.010	Why?
Drug Therapy, Combination	2	1981	1136	0.010	Why?
Rodentia	1	1980	44	0.010	Why?
Microsatellite Repeats	1	2001	230	0.010	Why?
Luminescent Proteins	1	2000	155	0.010	Why?
Cell Count	1	1980	215	0.010	Why?
Lymphoma, Non-Hodgkin	2	1983	152	0.010	Why?
Macromolecular Substances	1	2000	140	0.010	Why?
COS Cells	1	2000	244	0.010	Why?
Mitotic Index	1	1999	17	0.010	Why?
CpG Islands	1	2001	332	0.010	Why?
Blood-Brain Barrier	1	2000	139	0.010	Why?
Epithelial Cells	1	2003	869	0.010	Why?
Thymidine Kinase	1	1979	88	0.010	Why?
Precipitin Tests	1	1999	136	0.010	Why?
Green Fluorescent Proteins	1	2000	376	0.010	Why?
Leucine	1	1980	258	0.010	Why?
Lipids	1	1983	549	0.010	Why?
Molecular Probe Techniques	1	1999	23	0.010	Why?
Cyclin-Dependent Kinase Inhibitor p21	1	1999	82	0.010	Why?
Genetic Predisposition to Disease	1	2010	3256	0.010	Why?
Reagent Kits, Diagnostic	1	1999	52	0.010	Why?
Mutagens	1	1999	48	0.010	Why?
Adenocarcinoma, Mucinous	1	1999	39	0.010	Why?
Mortality	1	1980	249	0.010	Why?
DNA Mutational Analysis	1	2001	780	0.010	Why?
Calcium-Calmodulin-Dependent Protein Kinases	1	1999	103	0.010	Why?
Estradiol Congeners	1	1978	3	0.010	Why?
Testosterone Congeners	1	1978	16	0.010	Why?
Receptors, Androgen	2	1979	402	0.010	Why?
Fluoxymesterone	1	1998	1	0.010	Why?
Nucleic Acid Hybridization	1	1999	297	0.010	Why?
Mice, Transgenic	1	2003	2311	0.010	Why?
Oxygen	2	1973	540	0.010	Why?
DNA, Complementary	1	1999	435	0.010	Why?
Protein Structure, Tertiary	1	2000	721	0.010	Why?
Nuclear Receptor Co-Repressor 2	1	1998	31	0.010	Why?
Preoperative Care	1	2000	350	0.010	Why?
Neuromuscular Diseases	1	1998	48	0.010	Why?
Breast Diseases	1	1998	39	0.010	Why?
Neoplasms, Multiple Primary	1	1998	60	0.010	Why?
Hematologic Diseases	1	1998	72	0.010	Why?
Radiotherapy, Adjuvant	1	1998	151	0.010	Why?
Actuarial Analysis	2	1992	28	0.010	Why?
Aging	1	1984	1187	0.010	Why?
Drug Hypersensitivity	1	1998	97	0.010	Why?
Osteosarcoma	1	2000	258	0.010	Why?
Genes, Reporter	1	1998	344	0.010	Why?
Temperature	1	1978	282	0.010	Why?
Mitomycin	1	1997	48	0.010	Why?
Hydrogen-Ion Concentration	1	1978	420	0.010	Why?
Dactinomycin	1	1976	48	0.010	Why?
Glucose	2	1983	842	0.010	Why?
Pain Measurement	1	1998	345	0.010	Why?
Repetitive Sequences, Nucleic Acid	1	1997	354	0.010	Why?
Ascites	1	1997	98	0.010	Why?
Registries	1	2003	1477	0.010	Why?
Intracellular Signaling Peptides and Proteins	1	1999	579	0.010	Why?
Income	1	1996	127	0.010	Why?
Cell Fractionation	1	1995	23	0.010	Why?
Heterozygote	1	1998	690	0.010	Why?
Metaphase	1	1995	31	0.010	Why?
Pleural Effusion, Malignant	1	1995	13	0.010	Why?
Tomography, Emission-Computed	1	1995	36	0.010	Why?
Educational Status	1	1996	275	0.010	Why?
Testicular Neoplasms	1	1976	120	0.010	Why?
Multicenter Studies as Topic	1	1996	280	0.010	Why?
Buffers	1	1995	28	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1995	98	0.010	Why?
National Institutes of Health (U.S.)	1	1995	131	0.010	Why?
Receptors, Urokinase Plasminogen Activator	1	1995	25	0.010	Why?
Suppositories	1	1994	3	0.010	Why?
Gastrointestinal Diseases	1	1998	336	0.010	Why?
GRB7 Adaptor Protein	1	1994	2	0.010	Why?
Residence Characteristics	1	1996	269	0.010	Why?
Heart Diseases	1	1998	487	0.010	Why?
Hemoglobinuria	1	1973	2	0.010	Why?
Oligonucleotides, Antisense	1	1993	69	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	1995	781	0.010	Why?
Sequence Homology, Amino Acid	1	1994	622	0.010	Why?
Catalase	1	1973	63	0.010	Why?
Nitrites	1	1973	48	0.010	Why?
Lymphoma, Follicular	2	1983	27	0.010	Why?
Image Processing, Computer-Assisted	1	1995	588	0.010	Why?
Diet	1	1979	1102	0.010	Why?
Caenorhabditis elegans	1	1994	229	0.010	Why?
Ultraviolet Rays	1	1973	191	0.010	Why?
Sodium	1	1973	274	0.010	Why?
Ovarian Neoplasms	1	1995	443	0.010	Why?
Chromosome Mapping	1	1994	1065	0.010	Why?
Carcinoma, Hepatocellular	1	2000	968	0.010	Why?
Atmospheric Pressure	1	1970	5	0.010	Why?
Mass Spectrometry	1	1992	351	0.010	Why?
Adrenal Glands	1	1970	46	0.010	Why?
Splenectomy	1	1970	61	0.010	Why?
Aerospace Medicine	1	1970	39	0.010	Why?
Postoperative Care	1	1992	301	0.000	Why?
Spleen	1	1970	251	0.000	Why?
Blotting, Northern	1	1989	235	0.000	Why?
Leukocytes	1	1970	203	0.000	Why?
Genes, ras	1	1989	99	0.000	Why?
Ascitic Fluid	1	1988	29	0.000	Why?
Stress, Physiological	1	1970	256	0.000	Why?
Adrenal Cortex Hormones	1	1970	331	0.000	Why?
Surveys and Questionnaires	1	1998	3905	0.000	Why?
Proto-Oncogene Proteins c-myc	1	1989	192	0.000	Why?
Pleural Effusion	1	1988	106	0.000	Why?
Alopecia	1	1985	40	0.000	Why?
Vomiting	1	1985	99	0.000	Why?
Autopsy	1	1983	112	0.000	Why?
Infusions, Parenteral	1	1983	78	0.000	Why?
Deoxyglucose	1	1983	43	0.000	Why?
Endocrine Glands	1	1982	8	0.000	Why?
Phospholipids	1	1983	99	0.000	Why?
Methods	1	1982	122	0.000	Why?
Autoradiography	1	1982	65	0.000	Why?
B-Lymphocytes	1	1983	515	0.000	Why?
Cell Separation	1	1981	219	0.000	Why?
Eggs	1	1979	20	0.000	Why?
Steroids	1	1980	157	0.000	Why?
Milk	1	1979	106	0.000	Why?
Calcium	1	1983	1031	0.000	Why?
Dietary Fats	1	1979	271	0.000	Why?
Acute Disease	1	1980	1046	0.000	Why?
Prolactin	1	1977	111	0.000	Why?
Energy Intake	1	1979	495	0.000	Why?
Androgen Antagonists	1	1977	107	0.000	Why?
Lactation	1	1977	194	0.000	Why?
Androgens	1	1977	270	0.000	Why?
T-Lymphocytes	1	1983	1708	0.000	Why?
Heart Failure	1	1985	2175	0.000	Why?
Child	1	1983	25062	0.000	Why?

OSBORNE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (725)

Explore

Co-Authors (15)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors